We were also able to uncover species-specific molecular characteristics, such as uncertain role for ERBB2 amplification in CMTs, and mutations prevalent in benign tumors that may reflect the early genetic basis underlining the initiation of CMT pathogenesis. The gene discussed is ERBB2; the disease is Charcot-Marie-Tooth disease.